Filter the drugs by their COVID-19 status ,phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance COVID-19 status Phase of research How it helps  Latest publication
Genz-667161
Potential treatment - pre-clinical evidence Experimental Antiviral Feb/24/2021
Genz-123346
Potential treatment - pre-clinical evidence Experimental Antiviral Feb/24/2021
Infliximab
Potential treatment - clinical evidence Experimental Antiviral Feb/01/2021
(S)-3-((S)-3-(4-methoxyphenyl)-2-((S)-2-(2-morpholinoacetamido)propanamido) propanamido)-2-oxo-N,4-diphenylbutanamide
Potential treatment - pre-clinical evidence Experimental Antiviral Feb/10/2021
mAb 2-7
Potential treatment - pre-clinical evidence Experimental Antiviral Mar/08/2021
Imiglitazar
Potential treatment - theoretical effect Experimental Antiviral Feb/23/2021
rSIFN-co
Potential treatment - clinical evidence Experimental Antiviral Feb/23/2021
VHH WE
Potential treatment - pre-clinical evidence Experimental Antiviral Feb/12/2021
aRBD-2-7
Potential treatment - pre-clinical evidence Experimental Antiviral Mar/03/2021
VHH EW
Potential treatment - pre-clinical evidence Experimental Antiviral Feb/12/2021
MLN-4760
Potential treatment - theoretical effect Experimental Antiviral Mar/03/2021
hACE221-55A36K-F40E
Potential treatment - pre-clinical evidence Experimental Antiviral Mar/02/2021
VHH VE
Potential treatment - pre-clinical evidence Experimental Antiviral Feb/12/2021
VHH EV
Potential treatment - pre-clinical evidence Experimental Antiviral Feb/12/2021
VHH EEE
Potential treatment - pre-clinical evidence Experimental Antiviral Feb/12/2021
VHH EE
Potential treatment - pre-clinical evidence Experimental Antiviral Feb/12/2021
aRBD-2-5
Potential treatment - pre-clinical evidence Experimental Antiviral Mar/03/2021
S309
Potential treatment - pre-clinical evidence Experimental Antiviral Jun/22/2022
VHH W
Potential treatment - pre-clinical evidence Experimental Antiviral Feb/12/2021
VHH V
Potential treatment - pre-clinical evidence Experimental Antiviral Feb/12/2021